AIM-101 (NexImmune)

N/A

Report date: 2025/01/26 18:09:27

Base Information

Drug NameAIM-101 (NexImmune)
Drug Alias NameaAPC (NexImmune)CD28 costimulator-containing artificial antigen-presenting cell (NexImmune)artificial antigen-presenting cell (NexImmune)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT-cell-specific surface glycoprotein CD28 agonists
TargetsT-cell-specific surface glycoprotein CD28
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeximmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeximmune Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A